Is the Depo-Provera^® Lawsuit Settlement Real?

Yes, the Depo-Provera​​^® lawsuit settlement is real. In June 2026, Pfizer and attorneys representing thousands of women told a federal court they had reached a global settlement agreement in the Depo shot litigation — the most significant development in this case so far.

But the settlement news has also been widely misunderstood. Some women diagnosed with meningioma brain tumors after using Depo-Provera (medroxyprogesterone acetate) now believe the case is over, that a single payout amount has been set, or that they've missed their chance to take legal action.

None of that is true. The settlement is still being finalized, no financial terms have been announced, and new Depo shot claims are still being accepted, including by Sokolove Law.

As of August 2026, roughly 6,300 Depo-Provera claims have been filed in the federal multidistrict litigation (MDL) — up from just 550 only a year ago. The lawsuits allege the shot caused meningioma brain tumors and that its manufacturers failed to warn U.S. users of this risk.

Millions of women have used Depo-Provera and may still be at risk of developing tumors. These lawsuits have been filed against Pfizer Inc., the manufacturer of the shot, as well as associated companies like Pfizer’s former Pharmacia & Upjohn unit.

Hundreds of women have already turned to Sokolove Law for help understanding their legal options and filing a Depo shot claim. Don’t miss your chance to take action — get started now with a free case review.

Get a Free Case Review

Why Are There Depo Shot Lawsuits Against Pfizer?

As the manufacturer of Depo-Provera, Pfizer is responsible for ensuring their product's safety before it reaches patients. It's natural for drugs to come with side effects, but patients have the legal right to be warned of these effects ahead of time, so they can make an informed decision.

Depo shot lawsuits filed against Pfizer claim the company allegedly:

• Knew about the increased risk of meningiomas
• Failed to adequately study or monitor the neurological effects of the shot
• Marketed the product as safe for long-term use despite emerging risks
• Added the risk to warning labels in Canada and Europe but not in the U.S.
• Downplayed or omitted serious side effects in U.S. promotional materials
• Tried to pin the blame on the U.S. Food and Drug Administration (FDA) instead

These lawsuits argue that Pfizer put patients at unnecessary risk by withholding critical safety information from U.S. consumers. If the company had warned patients and health care providers about the potential link to meningiomas sooner, some may have chosen different birth control options.

As a result, legal action is now being taken to hold Pfizer accountable and seek compensation for those harmed. Because litigation is ongoing, affected women are still able to file a claim.

How Much Is the Depo-Provera Lawsuit Settlement?

On June 15, the federal judge overseeing the Depo-Provera MDL (MDL No. 3140 in the U.S. District Court for the Northern District of Florida), U.S. District Judge M. Casey Rodgers, confirmed that Pfizer and the victims' lead counsel had reached a global settlement agreement in principle.

It's important to understand what that phrase means: A settlement in principle is a framework for resolving claims — not a payment. It doesn't send anyone money yet, doesn't resolve any individual case, and doesn't close the litigation.

Here's what we know about the Depo shot settlement so far:

• Eligible MDL plaintiffs can resolve their claims. Under the framework, women with cases filed in the MDL who meet the eligibility criteria agreed to by the parties will have the opportunity to settle through a structured settlement program.
• The deal is still being finalized. The parties are working to memorialize the full terms. No dollar amounts, compensation tiers, or official eligibility criteria have been made public yet.
• The first trial has been taken off the calendar. After the settlement was announced, the court removed the first bellwether trial, which had been scheduled for December 2026, from its calendar — a strong signal that both sides expect the deal to move forward.
• State court cases are not included. The framework covers only the federal proceeding. Depo-Provera lawsuits filed in state courts, including cases pending in New York, Delaware, and New Mexico, remain untouched and are proceeding separately.
• Nothing is paid automatically to women who haven't filed. The agreement doesn't shut unfiled claimants out, but it doesn't compensate them either. To benefit, a woman generally needs a claim on file.

The June 2026 Depo-Provera settlement agreement means Pfizer may now compensate thousands of women without ever putting questions about the safety of the Depo shot in front of a jury. This would provide a quicker pathway to financial support for victims.

Why Did Pfizer Settle So Quickly?

Most pharmaceutical mass torts like Depo-Provera litigation only settle after years of test trials called bellwethers. In this case, the agreement came before a single trial — and after two major developments strengthened cases:

• A 2024 BMJ study linking the shot to a more than 5-fold increase in meningioma risk
• The FDA's December 2025 approval of a new U.S. warning label finally listing meningiomas as a risk

Together, these developments may have significantly increased pressure on Pfizer to resolve the claims before facing their first trial.

How Much Could the Depo Shot Settlement Pay?

The June 2026 settlement announcement did not include any information about dollar amounts, so any specific figure circulating online right now is a projection, not a result. That's partly because an MDL doesn't work like a class action, where members generally receive similar payments.

In the Depo-Provera litigation, each claim is evaluated on the strength of that woman's individual medical file. Settlement programs at this scale usually sort claims into tiers, meaning two women in the same agreement can receive very different amounts.

Factors that may affect the value of an individual claim include:

• Surgery: A meningioma removed through a craniotomy is generally valued differently than one being monitored with periodic scans. Radiation treatment, repeat operations, or a tumor that returned after treatment may further increase a claim's value.
• Permanent effects: Ongoing seizures, hearing or vision loss, and measurable cognitive changes support higher values than injuries that resolve without ongoing complications.
• Medical expenses: Compensation may account for the costs of surgery, stereotactic radiosurgery, medication, rehabilitation, and future care. Meningiomas can return years later, often requiring lifelong monitoring scans.
• Lost income: Wages lost during diagnosis and treatment, plus reduced earning capacity when symptoms like fatigue, memory trouble, or vision changes limit the work a woman can do.
• Pain and suffering: Physical pain, emotional distress, the fear that follows a brain tumor diagnosis, and the parts of daily life the diagnosis takes away. For severe or permanent injuries, this can be a large share of a payout.
• Strength of evidence: The length of treatment, whether it's documented in pharmacy and clinical records, and the timing between the last injection and the diagnosis.

Learn more about potential Depo shot settlement amounts and how compensation may be determined to get an idea of the value of your case.

When Is the Depo-Provera Lawsuit Payout Date?

With no official timeline announced, the Depo-Provera lawsuit payout date is unknown. Settlement registration and processing typically take several months, meaning the earliest Depo shot payouts could potentially begin in 2027.

However, once an individual Depo-Provera lawsuit settlement is approved, it may likely take 1-2 months for a settlement check to arrive.

Our Depo-Provera attorneys will work to keep each eligible claim moving forward as quickly as possible, helping avoid unnecessary delays in the settlement and payout process.

Who Qualifies for the Depo Shot Lawsuit Settlement?

The official Depo shot settlement eligibility criteria haven't been released yet. However, to qualify for a Depo shot claim, women generally need to have been diagnosed with a brain tumor after using this birth control for at least a year.

Find out more about Depo shot lawsuit qualifications:

• Use of Depo-Provera: The brain tumor patient must have used the Depo-Provera birth control injection, Depo-SubQ Provera 104, or an authorized generic form of the drug.
• Duration of Use: The individual must have used Depo-Provera for at least 1 year. Research has shown that long-term use significantly increases the risk of developing meningiomas.
• Diagnosis of a Meningioma: The individual must have been diagnosed with a meningioma brain tumor after using Depo-Provera.
• Taking Action Before the Deadline: There’s only a limited amount of time to file a Depo shot claim. If you wait too long, you may miss your chance to seek justice.

If you or a loved one meets the criteria, you may be able to file a lawsuit and pursue compensation that can help with medical costs, lost wages, and more.

Used a Generic Version of the Shot? You May Still Qualify

One common misconception keeps otherwise eligible women from coming forward: the belief that a generic injection is a different product. It isn't.

Generic birth control shots contain the exact same active ingredient as brand-name Depo-Provera (medroxyprogesterone acetate or MPA), so the same safety concerns apply, and the litigation covers both.

Many women can't say whether they received the brand-name or generic shot because pharmacies and clinics may make a substitute without always mentioning it. That uncertainty doesn't cancel out your right to file a claim. In fact, this question usually gets resolved in the claimant's favor.

Our legal team can review your medical history, analyze scientific research, and work with medical experts to help prove your meningioma was caused by the Depo shot.

What Does the Depo Shot Settlement Mean If You Haven't Filed Yet?

If you used Depo-Provera and were later diagnosed with a meningioma but haven't taken legal action, here's the most important thing to know: You may still be able to seek compensation, but time could be running out.

Here's what the settlement means for women who haven't filed yet:

• New cases are still being accepted. The Depo shot settlement framework covers cases pending in the MDL, and lawyers are continuing to file new claims for women who qualify while the deal is being finalized.
• The filing deadlines never stopped. The settlement announcement did not pause or extend any state's statute of limitations. In many states, the clock starts when you learned, or reasonably should have learned, that your tumor may be connected to the injection. That's why claims filed years after a last injection often remain viable.
• Waiting for settlement terms is a risk. A woman who waits for the terms to become public may watch her legal deadline pass in the meantime — and no amount of evidence can revive a claim filed too late.
• Start gathering medical records now. Whatever shape the final agreement takes, participating will require proof that you received the shot and that a meningioma diagnosis followed. Helpful records include pharmacy and clinic documentation of your injection schedule, imaging reports, and pathology findings if a tumor was removed. Incomplete records are common, especially when treatment goes back a decade or more. Our team can request records on your behalf.
• Settlement programs impose their own deadlines. On top of state legal deadlines, programs like this typically set registration and documentation cutoffs. Women whose cases are on file when those terms are announced are generally in the strongest position.

The bottom line: The settlement is a milestone, not a finish line. Thousands of women who used the Depo shot may not yet realize their brain tumor could be connected to it. If that's you or someone you love, now is the time to find out where you stand.

Call (800) 995-1212 now to see if our Depo-Provera attorneys may be able to help you file a birth control lawsuit.

Looking Ahead: What's Next in the Depo Shot Settlement?

The June 2026 agreement changed the shape of this litigation, but it didn't end it. Over the coming months, several steps will shape how and when the settlement pays out.

Here's what to watch as the Depo shot settlement moves forward:

• Finalizing the settlement terms: Both sides are working to put the full agreement in writing, including eligibility criteria, compensation tiers, and the claims process.
• Registration and claim review: Once the program opens, eligible plaintiffs will need to register and submit documentation, such as proof of Depo shot use and their meningioma diagnosis. A third-party reviewer began evaluating MDL complaints for completeness back in June 2025, so much of this groundwork is already underway.
• Participation thresholds: Global settlements like this one typically require a certain percentage of plaintiffs to opt in before the defendant funds the deal.
• State court litigation continues: Cases filed in state courts, which are not part of the MDL settlement, will keep moving forward and could result in additional settlements or verdicts.

Sokolove Law is closely following developments surrounding the settlement. Women who may qualify shouldn’t wait for the settlement process to move forward before exploring their legal options.

See If You Qualify to File a Lawsuit for the Depo Shot

At Sokolove Law, our Depo shot lawyers are dedicated to helping patients stand up to powerful pharmaceutical companies like Pfizer and fight for the compensation they deserve.

With decades of experience handling dangerous pharmaceutical drug cases, we can determine if you qualify for the Depo-Provera lawsuit and prepare a strong case on your behalf.

Our Depo shot law firm offers free case reviews to help you:

• Get answers to all of your questions
• Understand your legal rights and options
• Feel supported as you share your experiences
• Take a stand against the companies responsible
• See if you may qualify for compensation

We’ve successfully helped thousands of injured clients across all 50 states get justice, securing more than $10.5 Billion total nationwide.

Call (800) 995-1212 now to find out if you may be eligible for the Depo shot lawsuit.